ArchPoint Investors’s Zogenix, Inc. ZGNX Stock Holding History

ArchPoint Investors’s Portfolio ZGNX Stock Details ZGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,000	Closed	-$55K	–	142
2019 Q1	$55K	Buy	+1,000	New	+$47.6K	0.02%	108

Other funds holding ZGNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

ArchPoint Investors's ZGNX Position: Q2 2019 in Review

ArchPoint Investors sold out of Zogenix, Inc. (ZGNX) in Q2 2019, closing a stake of 1,000 shares — an estimated $55K sold.

ArchPoint Investors first reported a position in ZGNX in Q1 2019 and held it in 1 quarter. The position peaked at $55K in Q1 2019. 150 funds tracked by Wall St. Rank hold ZGNX as of Q2 2019.

ArchPoint Investors reported no remaining Zogenix, Inc. position as of Q2 2019 after selling out during the quarter.
ArchPoint Investors sold 1,000 Zogenix, Inc. shares in Q2 2019, an estimated $55K.
ArchPoint Investors first reported a position in Zogenix, Inc. in Q1 2019 and held it in 1 quarter.
ArchPoint Investors's Zogenix, Inc. position peaked at $55K in Q1 2019.
150 funds tracked by Wall St. Rank held Zogenix, Inc. as of Q2 2019.

Based on ArchPoint Investors's 13F filing for Q2 2019, filed 26 Jul 2019.